On the public citation graph

Clinical Efficacy of Moxifloxacin Versus Comparator Therapies for Community-Acquired Pneumonia Caused byLegionellaspp.

https://doi.org/10.1179/joc.2010.22.4.264
0 signed · 22 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.jinf.2007.09.010openalex-snapshot
Legionella spp. and Legionnaires' disease
inferredcites →https://doi.org/10.1086/498149openalex-snapshot
Treatment with Sequential Intravenous or Oral Moxifloxacin Was Associated with Faster Clinical Improvement than Was Standard Therapy for Hospitalized Patients with Community-Acquired Pneumonia Who Received Initial Parenteral Therapy
inferredcites →https://doi.org/10.1086/511159openalex-snapshot
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
inferredcites →https://doi.org/10.1086/586741openalex-snapshot
Community‐Acquired Legionella Pneumonia: New Insights from the German Competence Network for Community Acquired Pneumonia
inferredcites →https://doi.org/10.1093/jac/47.2.147openalex-snapshot
Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila
inferredcites →https://doi.org/10.1128/aac.46.6.1746-1754.2002openalex-snapshot
Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment
inferredcites →https://doi.org/10.1164/rccm.200603-350ocopenalex-snapshot
A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia
inferredcites →https://doi.org/10.1183/09031936.05.00055705openalex-snapshot
Guidelines for the management of adult lower respiratory tract infections

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4526511openalex-extracted
Clarithromycin for Early Anti-Inflammatory Responses in Community-Acquired Pneumonia: The ACCESS Randomized Trial
inferred← citeshttps://doi.org/10.1007/s00134-016-4394-4openalex-snapshot
Community-acquired pneumonia related to intracellular pathogens
inferred← citeshttps://doi.org/10.1007/s11908-012-0251-yopenalex-snapshot
Are Fluoroquinolones Superior Antibiotics for the Treatment of Community-Acquired Pneumonia?
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00137-0openalex-snapshot
Legionnaires’ Disease, Pontiac Fever, and Related Illnesses
inferred← citeshttps://doi.org/10.1016/s0140-6736(15)60078-2openalex-snapshot
Legionnaires' disease
inferred← citeshttps://doi.org/10.1016/s1473-3099(14)70713-3openalex-snapshot
Epidemiology and clinical management of Legionnaires' disease
inferred← citeshttps://doi.org/10.1016/s2213-2600(23)00412-5openalex-snapshot
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1055/a-0662-9330openalex-snapshot
Legionella und Legionellose
inferred← citeshttps://doi.org/10.2169/internalmedicine.4530-20openalex-snapshot
Fatal Fulminant Legionnaires' Disease in a Patient on Maintenance Hemodialysis
inferred← citeshttps://doi.org/10.26442/20751753.2023.9.202408openalex-snapshot
Community-acquired pneumonia: antibiotic therapy approach after the COVID-19 pandemic. A review
inferred← citeshttps://doi.org/10.3389/fmed.2024.1329381openalex-snapshot
Multiple pulmonary cavities in an immunocompetent patient: a case report and literature review
inferred← citeshttps://doi.org/10.52711/0974-360x.2022.00979openalex-snapshot
Pharmacokinetic properties of Fluoroquinolones in Comparative Aspect of their effect on Pathogenic microflora
inferred← citeshttps://doi.org/10.5772/intechopen.83129openalex-snapshot
Hospital Acquired Infection and Legionnaires' Disease
inferred← citeshttps://doi.org/10.5772/intechopen.88471openalex-snapshot
Legionnaires’ Disease Treatment
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.